ACRS
Aclaris Therapeutics Inc
3.70$
-13.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -3,248.0% | -999.0% | -2,281.6% | -596.0% | -771.1% | -227.1% | -250.6% | -107.2% | -602.0% | |
| – | – | – | – | 23.9% | 18.6% | 37.5% | 20.4% | 13.7% | 2.7% | 2.8% | 4.3% | 5.8% | |
| – | – | – | – | 857.4% | 198.7% | 382.7% | 172.9% | 208.0% | 50.5% | 65.7% | 58.0% | 158.2% | |
| – | – | – | – | 748.2% | 211.3% | 1,491.7% | 207.0% | 579.1% | 66.3% | – | – | – | |
| – | – | – | – | 51.4% | 93.5% | -63.9% | -36.4% | -19.9% | -4.0% | 30.0% | 58.3% | 34.1% | |
| – | – | – | – | 73.4% | 13.4% | 38.2% | 7.0% | 4.6% | 2.0% | 4.2% | 0.6% | 1.4% | |
| – | – | – | – | -3,309.1% | 92.8% | 2,500.1% | 98.5% | -2,479.4% | 42.4% | 147.9% | -372.7% | 618.0% | |
| – | – | – | – | 0.0% | – | – | 119.4% | 46.2% | – | – | – | – | |
| – | – | – | – | 5,969.3% | 998.7% | 4.9% | 119.4% | -46.2% | -0.1% | -0.3% | – | -5.7% | |
| – | – | – | – | -4.6% | 290.0% | -709.7% | 168.4% | -169.8% | 0.0% | 0.0% | – | – | |
| – | – | – | – | 5,964.7% | 1,271.0% | -717.2% | 283.4% | 3,328.7% | 244.9% | 85.5% | 398.2% | -74.9% | |
| – | – | – | – | -592.3% | 364.8% | -498.7% | -214.0% | 78.2% | 60.3% | -17.3% | -81.8% | -58.9% | |
| – | – | – | – | -3,321.3% | -1,012.5% | -2,319.8% | -603.0% | -775.7% | -229.1% | -254.8% | -107.9% | -602.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.